Literature DB >> 28625397

Quantitative evaluation of heartbeat interval time series using Poincaré analysis reveals distinct patterns of heart rate dynamics during cycles of vagus nerve stimulation in patients with heart failure.

Imad Libbus1, Bruce D Nearing2, Badri Amurthur1, Bruce H KenKnight1, Richard L Verrier3.   

Abstract

BACKGROUND: Optimization of stimulation parameters is essential to maximizing therapeutic efficacy and minimizing side effects.
METHODS: The ANTHEM-HF study enrolled patients with heart failure who received chronic autonomic regulation therapy (ART) with an implantable vagus nerve stimulation (VNS) system on either the right (n=30) or left side (n=29). Acute effects of continuously cycling VNS on R-R interval dynamics were evaluated using post hoc Poincaré analysis of ECG recordings collected during multiple titration sessions over an 8-12week period. During each titration session, VNS intensity associated with maximum tolerable dose was determined. Poincaré plots of R-R interval time series were created for epochs when VNS cycled from OFF to ON at varying intensity levels.
RESULTS: VNS produced an immediate, relatively small change in beat-to-beat distribution of R-R intervals during the 14-sec ON time, which was correlated with stimulation current amplitude (r=0.85, p=0.05). During titration of right-sided stimulation, there was a strong correlation (r=0.91, p=0.01) between stimulus intensity and the Poincaré parameter of standard deviation, SD1, which is associated with high-frequency heart rate variability. The effect of VNS on instantaneous heart rate was indicated by a shift in the centroid of the beat-to-beat cloud distribution demarcated by the encircling ellipse. As anticipated, left-sided stimulation did not alter any Poincaré parameter except at high stimulation intensities (≥2mA).
CONCLUSION: Quantitative Poincaré analysis reveals a tight coupling in beat-to-beat dynamics during VNS ON cycles that is directly related to stimulation intensity, providing a useful measurement for confirming autonomic engagement.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autonomic regulation therapy; Heart failure; Poincaré; Vagus nerve stimulation

Mesh:

Year:  2017        PMID: 28625397     DOI: 10.1016/j.jelectrocard.2017.06.007

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  6 in total

1.  Sex Differences in Vagus Nerve Stimulation Effects on Rat Cardiovascular and Immune Systems.

Authors:  Farid Yaghouby; Kee Jang; Uyen Hoang; Sepideh Asgari; Srikanth Vasudevan
Journal:  Front Neurosci       Date:  2020-11-06       Impact factor: 4.677

2.  Stochastic vagus nerve stimulation affects acute heart rate dynamics in rats.

Authors:  Steven W Lee; Kanchan Kulkarni; Elizabeth M Annoni; Imad Libbus; Bruce H KenKnight; Elena G Tolkacheva
Journal:  PLoS One       Date:  2018-03-28       Impact factor: 3.240

Review 3.  Vagal stimulation in heart failure.

Authors:  Veronica Dusi; Gaetano Maria De Ferrari
Journal:  Herz       Date:  2021-10-30       Impact factor: 1.443

4.  Persistent Autonomic Engagement and Cardiac Control After Four or More Years of Autonomic Regulation Therapy Using Vagus Nerve Stimulation.

Authors:  Imad Libbus; Rajendra K Premchand; Kamal Sharma; Sanjay Mittal; Rufino Monteiro; Badri Amurthur; Bruce H KenKnight; Lorenzo A DiCarlo; Inder S Anand
Journal:  Front Physiol       Date:  2022-03-11       Impact factor: 4.566

Review 5.  Autonomic Modulation of Cardiac Arrhythmias: Methods to Assess Treatment and Outcomes.

Authors:  Stavros Stavrakis; Kanchan Kulkarni; Jagmeet P Singh; Demosthenes G Katritsis; Antonis A Armoundas
Journal:  JACC Clin Electrophysiol       Date:  2020-05

6.  Shoulder transcutaneous electric nerve stimulation decreases heart rate via potentiating vagal tone.

Authors:  Chun-Ming Hsieh; Hsien-Yu Peng; Wan-Chen Lin; Huang-Chung Chen; Yu-Cheng Ho; Chi-Jui Li; Xi-Guan Wu; Jen-Yi Chung; Shin-Da Lee; Tzer-Bin Lin
Journal:  Sci Rep       Date:  2021-09-27       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.